Company Filing History:
Years Active: 2001
Title: Claudia Kappen: Innovator in Tissue-Specific Regulatory Elements
Introduction
Claudia Kappen is a prominent inventor based in Scottsdale, AZ (US). She has made significant contributions to the field of molecular biology, particularly in the regulation of nucleic acid expression. Her innovative work has implications for various applications in medical research and biotechnology.
Latest Patents
Claudia Kappen holds 1 patent related to her invention titled "Tissue-specific regulatory elements." This invention provides methods and materials that are crucial for the regulation of nucleic acid expression. Specifically, it includes midbrain-specific and NS-specific regulatory elements, as well as elements that enhance nucleic acid expression and those that work in conjunction with other regulatory elements. Additionally, the invention introduces temporal regulatory elements that control nucleic acid expression over time. It also encompasses nucleic acid constructs that integrate these regulatory elements with selected nucleic acid sequences. Furthermore, the invention includes cells and animals that incorporate these regulatory elements and constructs, along with methods for delivering a selected nucleic acid sequence that is expressed in a tissue-specific or temporal manner.
Career Highlights
Claudia Kappen is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research and innovations. Her work is recognized for its potential to enhance understanding and treatment of various medical conditions through targeted gene expression.
Collaborations
Claudia has collaborated with Paul John Yaworsky, contributing to the advancement of research in her field. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Claudia Kappen's contributions to the field of tissue-specific regulatory elements highlight her role as a leading inventor in molecular biology. Her innovative approaches have the potential to significantly impact medical research and biotechnology.